In another cell culture model, genome-wide CRISPR-Cas9 knockout screen revealed SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinoma (HCC) (14). This evidence concerns the gene SGO1 and hepatocellular carcinoma.